Approval · Notice of Compliance 109 · 2004
ACULAR LS: Notice of Compliance 109
Issued January 12, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 109
- Date
- January 12, 2004
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 0.4%; new name: acular ls; new indication: for the reduction of ocular pain and ocular symptoms of foreign body sensation, burning/stinging, tearing, and photophobia following refractive surgery
- Therapeutic class
- Topical non-steroidal anti-inflammatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACULAR LS | 02248722 | Cancelled Post Market |
Medicinal ingredients
- KETOROLAC TROMETHAMINE 0.4 PER